Skip to main content

Advertisement

SpringerLink
Log in

Criteria for liver resection for metastasis from bile duct cancer

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Background

The surgical indications for liver metastasis from bile duct cancer remain contentious, because surgery is generally thought unlikely to improve survival. However, recent reports show that long-term survival has been achieved with liver resection of metastasis from recurrent bile duct cancer in selected patients.

Methods

Liver resection for liver metastasis from bile duct cancer was proposed only when the following criteria were met: liver-only metastasis, a solitary tumor, and no increase in the number of lesions during 3 months of observation. This study aimed to validate our criteria and to analyze which factors impact on survival.

Result

Between 2003 and 2017, 164 patients underwent pathologically curative resection for bile duct cancer. Recurrence developed in 98 of these patients, as liver-only metastasis in 25. Eleven of these 25 patients underwent liver resection (liver resection group), and 14 did not (non-liver resection group). The median overall survival was longer in the liver resection group than in all the patients (44 months vs. 17.8 months, respectively p = 0.040). The median overall survival was better in the liver resection group than in the non-liver resection group (44 months vs. 19.9 months, p = 0.012). The disease-free interval was also significantly longer in the liver resection group than in the non-liver resection group [22 months (range; 4–34 months) vs. 3 months (2–11), p < 0.001].

Conclusion

Potentially, metachronous solitary liver metastasis from bile duct cancer is an indication for liver resection when the patient has had a long disease-free interval. Observation for 3 months from first detection of metastasis may optimize the selection for this surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gleisner AL, Assumpcao L, Cameron JL, Wolfgang CL, Choti MA, Herman JM, et al. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified? Cancer. 2007;110:2484–92.

    Article  Google Scholar 

  2. De Jong MC, Farnell MB, Sclabas G, Cunningham SC, Cameron JL, Geschwind JF, et al. Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis. Ann Surg. 2010;252:142–8.

    Article  Google Scholar 

  3. Wellner UF, Shen Y, Keck T, Jin WY, Xu Z. The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival. Surg Today. 2017;47:271–9.

    Article  CAS  Google Scholar 

  4. Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689–700.

    Article  Google Scholar 

  5. Koerkamp BG, Wiggers JK, Allen PJ, Besselink MG, Blumgart LH, Busch ORC, et al. Recurrence rate and pattern of Perihilar Cholangiocarcinoma after curative intent resection. J Am Coll Surg. 2015;221:1041–9.

    Article  Google Scholar 

  6. Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, et al. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach. Surgery. 2018;163:732–8.

    Article  Google Scholar 

  7. Ito Y, Abe Y, Egawa T, Kitago M, Itano O, Kitagawa Y, et al. Predictive factors of early recurrence in patients with distal cholangiocarcinoma after pancreaticoduodenectomy. Gastroenterol Res Pract. 2018;3(2018):6431254.

    Google Scholar 

  8. Malka D, Cervera P, Foulon S, Trarbach T, Fouchardière C, Boucher E, et al. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial. Lancet Oncol. 2014;15:819–28.

    Article  CAS  Google Scholar 

  9. Brieau B, Dahan L, De Rycke Y, Boussaha T, Vasseur P, Tougeron D, et al. Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: a large multicenter study by the Association des Gastro-Entérologues Oncologues. Cancer. 2015;121:3290–7.

    Article  CAS  Google Scholar 

  10. Kim BJ, Yoo C, Kim KP, Hyung J, Park SJ, Ryoo BY, et al. Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients. Br J Cancer. 2017;116:561–7.

    Article  CAS  Google Scholar 

  11. Hayashibe A, Kameyama M. Clinical results of intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of biliary tract cancer. HPB. 2008;10:144–7.

    Article  CAS  Google Scholar 

  12. Kurosaki I, Minagawa M, Kitami C, Takano K, Hatakeyama K. Hepatic resection for liver metastases from carcinomas of the distal bile duct and of the papilla of Vater. Langenbecks Arch Surg. 2011;396:607–13.

    Article  Google Scholar 

  13. Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, De Jong MC, et al. Hepatectomy for Noncolorectal Non-Neuroendocrine Metastatic Cancer: A Multi-Institutional Analysis. J Am Coll Surg. 2012;214:769–77.

    Article  Google Scholar 

  14. Komaya K, Ebata T, Shirai K, Ohira S, Morofuji N, Akutagawa A, et al. Recurrence after resection with curative intent for distal cholangiocarcinoma. Br J Surg. 2017;104:426–33.

    Article  CAS  Google Scholar 

  15. Lee RC, Kanhere H, Trochsler M, Broadbridge V, Maddern G, Price TJ. Pancreatic, periampullary and biliary cancer with liver metastases: should we consider resection in selected cases? World J Gastrointest Oncol. 2018;10:211–20.

    Article  Google Scholar 

  16. Takao S, Shinchi H, Uchikura K, Kubo M, Aikou T. Liver metastases after curative resection in patients with distal bile duct cancer. Br J Surg. 1999;86:327–31.

    Article  CAS  Google Scholar 

  17. De Jong MC, Tsai S, Cameron JL, Wolfgang CL, Hirose K, van Vledder MG, et al. Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis. J Surg Oncol. 2010;102:256–63.

    Article  Google Scholar 

  18. Yamazaki S, Takayama T, Moriguchi M, Mitsuka Y, Okada S, Midorikawa Y, et al. Criteria for drain removal following liver resection. Br J Surg. 2012;99:1584–90.

    Article  CAS  Google Scholar 

  19. Wakai T, Shirai Y, Tsuchiya Y, Nomura T, Akazawa K, Hatakeyama K. Combined major hepatectomy and pancreaticoduodenectomy for locally advanced biliary carcinoma: long-term results. World J Surg. 2008;32:1067–74.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Digestive Surgery, Nihon University School of Medicine, 30-1 Ohyaguchikami-machi, Itabashi-ku, Tokyo, 173-8610, Japan

    Shintaro Yamazaki, Tadatoshi Takayama, Yusuke Mitsuka, Nao Yoshida & Tokio Higaki

Authors
  1. Shintaro Yamazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tadatoshi Takayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yusuke Mitsuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nao Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tokio Higaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tadatoshi Takayama.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamazaki, S., Takayama, T., Mitsuka, Y. et al. Criteria for liver resection for metastasis from bile duct cancer. Surg Today 51, 727–732 (2021). https://doi.org/10.1007/s00595-020-02159-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-020-02159-4

Keywords

Search

Navigation